Stegostoma fasciatum isolate 6-17 chromosome 33, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039259.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
complement C4-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
complement C4-like, transcript variant X3
complement C4-like, transcript variant X2
complement C4-like, transcript variant X4
complement C4-like, transcript variant X5
protein phosphatase 1 regulatory subunit 1A-like, transcript variant X1
protein phosphatase 1 regulatory subunit 1A-like, transcript variant X2
protein phosphatase 1 regulatory subunit 1A-like isoform X1
protein phosphatase 1 regulatory subunit 1A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unc-93 homolog B1, TLR signaling regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
unc-93 homolog B1, TLR signaling regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
unc-93 homolog B1, TLR signaling regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
SPG21 abhydrolase domain containing, maspardin, transcript variant X5
SPG21 abhydrolase domain containing, maspardin, transcript variant X7
SPG21 abhydrolase domain containing, maspardin, transcript variant X3
SPG21 abhydrolase domain containing, maspardin, transcript variant X4
SPG21 abhydrolase domain containing, maspardin, transcript variant X1
SPG21 abhydrolase domain containing, maspardin, transcript variant X6
SPG21 abhydrolase domain containing, maspardin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
zinc finger protein 239-like, transcript variant X1
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X3
zinc finger protein 239-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ankyrin repeat and death domain containing 1A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and death domain-containing protein 1A
small nuclear ribonucleoprotein polypeptide A'
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-1-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain-containing family O member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
leucine-rich repeat serine/threonine-protein kinase 1
aldehyde dehydrogenase 1 family, member A3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aldehyde dehydrogenase 1 family, member A3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldehyde dehydrogenase 1 family, member A3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
aldehyde dehydrogenase family 1 member A3 isoform X2
aldehyde dehydrogenase family 1 member A3 isoform X3
aldehyde dehydrogenase family 1 member A3 isoform X1
ankyrin repeat and SOCS box containing 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ankyrin repeat and SOCS box protein 7 isoform X1
ankyrin repeat and SOCS box protein 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ceramide synthase 3a, transcript variant X5
ceramide synthase 3a, transcript variant X1
ceramide synthase 3a, transcript variant X2
ceramide synthase 3a, transcript variant X3
ceramide synthase 3a, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif, 17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 17
membrane integral NOTCH2 associated receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
major intrinsically disordered Notch2-binding receptor 1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)
complement C1q tumor necrosis factor-related protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC125467104 isoform X2
complement C1q tumor necrosis factor-related protein 3-like isoform X1
bcl-2-related protein A1-like, transcript variant X1
bcl-2-related protein A1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
fumarylacetoacetate hydrolase (fumarylacetoacetase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator 2 isoform X1
aryl hydrocarbon receptor nuclear translocator 2 isoform X4
aryl hydrocarbon receptor nuclear translocator 2 isoform X2
aryl hydrocarbon receptor nuclear translocator 2 isoform X3
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X6
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator 2 isoform X5
aryl hydrocarbon receptor nuclear translocator 2 isoform X6
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X8
aryl hydrocarbon receptor nuclear translocator 2 isoform X7
abhydrolase domain containing 17C, depalmitoylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
alpha/beta hydrolase domain-containing protein 17C
cell surface hyaluronidase-like, transcript variant X2
cell surface hyaluronidase-like, transcript variant X1
cell surface hyaluronidase-like, transcript variant X3
cell surface hyaluronidase-like, transcript variant X4
cell surface hyaluronidase-like, transcript variant X6
cell surface hyaluronidase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cell surface hyaluronidase-like isoform X1
cell surface hyaluronidase-like isoform X2
cell surface hyaluronidase-like isoform X3
cell surface hyaluronidase-like isoform X5
cell surface hyaluronidase-like isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
cell migration-inducing and hyaluronan-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 161
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cilia- and flagella-associated protein 161
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
StAR-related lipid transfer (START) domain containing 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
elongation factor like GTPase 1, transcript variant X2
elongation factor like GTPase 1, transcript variant X1
elongation factor like GTPase 1, transcript variant X3
elongation factor-like GTPase 1 isoform X2
elongation factor-like GTPase 1 isoform X1
elongation factor-like GTPase 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
uncharacterized protein LOC791214 homolog, transcript variant X11
uncharacterized protein LOC791214 homolog, transcript variant X12
uncharacterized protein LOC791214 homolog, transcript variant X6
uncharacterized protein LOC791214 homolog, transcript variant X10
uncharacterized protein LOC791214 homolog, transcript variant X1
uncharacterized protein LOC791214 homolog, transcript variant X7
uncharacterized protein LOC791214 homolog, transcript variant X2
uncharacterized protein LOC791214 homolog, transcript variant X3
uncharacterized protein LOC791214 homolog, transcript variant X4
uncharacterized protein LOC791214 homolog, transcript variant X9
uncharacterized protein LOC791214 homolog, transcript variant X5
uncharacterized protein LOC791214 homolog, transcript variant X8
E3 ubiquitin-protein ligase MARCHF3 isoform X2
E3 ubiquitin-protein ligase MARCHF3 isoform X1
SH3-domain GRB2-like 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein basonuclin-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein basonuclin-2 isoform X2
hepatoma-derived growth factor-related protein 3-like
transmembrane 6 superfamily member 1-like
isocitrate dehydrogenase [NADP], mitochondrial
zinc finger protein 710a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 710a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 710a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 710a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 710a, transcript variant X3
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X9
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X14
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X6
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X5
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X7
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X11
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X10
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X13
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X17
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba
ras and EF-hand domain-containing protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras and EF-hand domain-containing protein, transcript variant X3
ras and EF-hand domain-containing protein, transcript variant X1
ras and EF-hand domain-containing protein, transcript variant X2
ras and EF-hand domain-containing protein isoform X1
ras and EF-hand domain-containing protein isoform X2
ras and EF-hand domain-containing protein isoform X3
ras and EF-hand domain-containing protein isoform X4
small EDRK-rich factor 2a, transcript variant X4
small EDRK-rich factor 2a, transcript variant X3
small EDRK-rich factor 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
small EDRK-rich factor 2a, transcript variant X5
small EDRK-rich factor 2a, transcript variant X1
FKBP prolyl isomerase 16, transcript variant X2
FKBP prolyl isomerase 16, transcript variant X1
RNA polymerase II elongation factor ELL, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RNA polymerase II elongation factor ELL, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RNA polymerase II elongation factor ELL isoform X1
RNA polymerase II elongation factor ELL isoform X2
RNA polymerase II elongation factor ELL, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA polymerase II elongation factor ELL isoform X6
RNA polymerase II elongation factor ELL, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA polymerase II elongation factor ELL, transcript variant X4
RNA polymerase II elongation factor ELL isoform X3
RNA polymerase II elongation factor ELL isoform X4
RNA polymerase II elongation factor ELL, transcript variant X5
RNA polymerase II elongation factor ELL isoform X5
multiple C2 and transmembrane domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125467340, transcript variant X2
uncharacterized LOC125467340, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
COUP transcription factor 2, transcript variant X5
COUP transcription factor 2, transcript variant X1
COUP transcription factor 2, transcript variant X3
COUP transcription factor 2, transcript variant X4
COUP transcription factor 2, transcript variant X2
uncharacterized LOC125467311, transcript variant X2
uncharacterized LOC125467311, transcript variant X1
arrestin domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
LysM, putative peptidoglycan-binding, domain containing 4
lysM and putative peptidoglycan-binding domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X6
myocyte enhancer factor 2aa, transcript variant X11
myocyte enhancer factor 2aa, transcript variant X10
myocyte enhancer factor 2aa, transcript variant X8
myocyte enhancer factor 2aa, transcript variant X1
myocyte enhancer factor 2aa, transcript variant X9
myocyte enhancer factor 2aa, transcript variant X7
myocyte enhancer factor 2aa, transcript variant X2
myocyte enhancer factor 2aa, transcript variant X3
myocyte enhancer factor 2aa, transcript variant X5
myocyte enhancer factor 2aa, transcript variant X4
leucine rich repeat containing 28, transcript variant X2
leucine rich repeat containing 28, transcript variant X1
leucine-rich repeat-containing protein 28 isoform X2
leucine-rich repeat-containing protein 28 isoform X1
leucine rich repeat containing 28, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
leucine-rich repeat-containing protein 28 isoform X3
cation channel sperm-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
protein disulfide isomerase family A, member 3
protein unc-13 homolog C-like, transcript variant X2
protein unc-13 homolog C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein unc-13 homolog C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein unc-13 homolog C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein unc-13 homolog C-like, transcript variant X5
protein unc-13 homolog C-like isoform X1
protein unc-13 homolog C-like isoform X3
protein unc-13 homolog C-like isoform X2
protein unc-13 homolog C-like isoform X4
probable ribosome biogenesis protein RLP24
RAB27A, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X7
RAB27A, member RAS oncogene family, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal assembly factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dynein axonemal assembly factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125467355, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125467355, transcript variant X2
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X2
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X5
E3 ubiquitin-protein ligase NEDD4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEDD4-like isoform X4
E3 ubiquitin-protein ligase NEDD4-like isoform X3
E3 ubiquitin-protein ligase NEDD4-like isoform X2
E3 ubiquitin-protein ligase NEDD4-like isoform X1
E3 ubiquitin-protein ligase NEDD4-like isoform X5
testis expressed 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
testis expressed 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
testis expressed 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
testis expressed 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
testis expressed 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
testis expressed 9, transcript variant X1
meiosis-specific nuclear structural 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
meiosis-specific nuclear structural 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
meiosis-specific nuclear structural protein 1 isoform X2
meiosis-specific nuclear structural protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 280D, transcript variant X3
zinc finger protein 280D, transcript variant X2
zinc finger protein 280D, transcript variant X1
transcription factor 12, transcript variant X3
transcription factor 12, transcript variant X4
transcription factor 12, transcript variant X5
transcription factor 12, transcript variant X1
transcription factor 12, transcript variant X6
transcription factor 12, transcript variant X7
transcription factor 12, transcript variant X2
transcription factor 12, transcript variant X8
transcription factor 12, transcript variant X9
uncharacterized LOC125467118, transcript variant X3
uncharacterized LOC125467118, transcript variant X1
uncharacterized LOC125467118, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
RNA polymerase II subunit M, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RNA polymerase II subunit M, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aldehyde dehydrogenase 1 family, member A2, transcript variant X2
aldehyde dehydrogenase 1 family, member A2, transcript variant X1
lipase, hepatic a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lipase, hepatic a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatic triacylglycerol lipase isoform X1
hepatic triacylglycerol lipase isoform X3
lipase, hepatic a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lipase, hepatic a, transcript variant X3
hepatic triacylglycerol lipase isoform X2
disintegrin and metalloproteinase domain-containing protein 10
MINDY lysine 48 deubiquitinase 2, transcript variant X1
MINDY lysine 48 deubiquitinase 2, transcript variant X2
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X1
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X2
SAFB-like transcription modulator, transcript variant X3
SAFB-like transcription modulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SAFB-like transcription modulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SAFB-like transcription modulator isoform X2
SAFB-like transcription modulator isoform X1
SAFB-like transcription modulator isoform X3
ring finger protein 111, transcript variant X1
ring finger protein 111, transcript variant X2
E3 ubiquitin-protein ligase Arkadia isoform X1
E3 ubiquitin-protein ligase Arkadia isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
centrosomal protein 152, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centrosomal protein 152, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centrosomal protein 152, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X1
SHC-transforming protein 4-like isoform X3
SHC-transforming protein 1-like isoform X2
SHC-transforming protein 1-like isoform X1
SHC-transforming protein 1-like isoform X4
SHC-transforming protein 1-like isoform X5
regulator of G-protein signaling 7-binding protein-like, transcript variant X1
regulator of G-protein signaling 7-binding protein-like, transcript variant X2
regulator of G-protein signaling 7-binding protein-like isoform X1
regulator of G-protein signaling 7-binding protein-like isoform X2
SECIS binding protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SECIS binding protein 2-like, transcript variant X2
SECIS binding protein 2-like, transcript variant X1
SECIS binding protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SECIS binding protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
selenocysteine insertion sequence-binding protein 2-like isoform X3
selenocysteine insertion sequence-binding protein 2-like isoform X2
selenocysteine insertion sequence-binding protein 2-like isoform X1
selenocysteine insertion sequence-binding protein 2-like isoform X4
COP9 signalosome subunit 2, transcript variant X3
COP9 signalosome subunit 2, transcript variant X2
COP9 signalosome subunit 2, transcript variant X1
COP9 signalosome complex subunit 2 isoform X3
COP9 signalosome complex subunit 2 isoform X2
COP9 signalosome complex subunit 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein FAM227B-like, transcript variant X2
protein FAM227B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DTW domain containing 1, transcript variant X2
DTW domain containing 1, transcript variant X3
DTW domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DTW domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DTW domain containing 1, transcript variant X4
tRNA-uridine aminocarboxypropyltransferase 1 isoform X1
tRNA-uridine aminocarboxypropyltransferase 1 isoform X2
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X2
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X1
NAD(P) transhydrogenase, mitochondrial-like
ATPase phospholipid transporting 8B4, transcript variant X2
ATPase phospholipid transporting 8B4, transcript variant X1
ATPase phospholipid transporting 8B4, transcript variant X3
ATPase phospholipid transporting 8B4, transcript variant X4
phospholipid-transporting ATPase ID isoform X1
phospholipid-transporting ATPase ID isoform X2
WD repeat-containing protein 72-like, transcript variant X1
WD repeat-containing protein 72-like, transcript variant X2
WD repeat-containing protein 72-like isoform X1
WD repeat-containing protein 72-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X3
family with sequence similarity 214 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
unconventional myosin-Vc-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unconventional myosin-Vc-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unconventional myosin-Vc-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unconventional myosin-Vc-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unconventional myosin-Vc-like isoform X1
unconventional myosin-Vc-like isoform X2
unconventional myosin-Vc-like isoform X3
unconventional myosin-Vc-like isoform X4
guanine nucleotide-binding protein subunit beta-5, transcript variant X1
guanine nucleotide-binding protein subunit beta-5, transcript variant X2
guanine nucleotide-binding protein subunit beta-5 isoform X1
guanine nucleotide-binding protein subunit beta-5 isoform X2
mitogen-activated protein kinase 6, transcript variant X5
mitogen-activated protein kinase 6, transcript variant X1
mitogen-activated protein kinase 6, transcript variant X4
mitogen-activated protein kinase 6, transcript variant X2
mitogen-activated protein kinase 6, transcript variant X3
mitogen-activated protein kinase 6, transcript variant X6
LEO1 homolog, Paf1/RNA polymerase II complex component
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X2
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
lysM and putative peptidoglycan-binding domain-containing protein 2
secretogranin III, transcript variant X2
secretogranin III, transcript variant X1
adaptor related protein complex 4 subunit epsilon 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor, alpha-induced protein 8-like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tumor necrosis factor, alpha-induced protein 8-like 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tumor necrosis factor alpha-induced protein 8-like protein 3 isoform X2
tumor necrosis factor alpha-induced protein 8-like protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 298 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 297 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X6
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X7
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X2
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X8
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X6
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X2
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X3
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X3
solute carrier family 24 member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 24 member 5, transcript variant X2
sodium/potassium/calcium exchanger 5 isoform X1
sodium/potassium/calcium exchanger 5 isoform X2
myelin expression factor 2, transcript variant X1
myelin expression factor 2, transcript variant X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch repeat and BTB domain containing 13a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
kelch repeat and BTB domain-containing protein 13
dipeptidyl peptidase 8-like, transcript variant X2
RAS-like, family 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ras-like protein family member 12 isoform X1
RAS-like, family 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-like protein family member 12 isoform X2
solute carrier family 51 subunit beta, transcript variant X2
solute carrier family 51 subunit beta, transcript variant X1
dipeptidyl peptidase 8-like, transcript variant X1
immunoglobulin superfamily, DCC subclass, member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily DCC subclass member 4
immunoglobulin superfamily, DCC subclass, member 3, transcript variant X2
immunoglobulin superfamily, DCC subclass, member 3, transcript variant X1
immunoglobulin superfamily DCC subclass member 3 isoform X1
immunoglobulin superfamily DCC subclass member 3 isoform X2
uncharacterized LOC125467089, transcript variant X4
uncharacterized LOC125467089, transcript variant X3
uncharacterized LOC125467089, transcript variant X1
uncharacterized LOC125467089, transcript variant X2
uncharacterized protein LOC125467089 isoform X3
uncharacterized protein LOC125467089 isoform X2
uncharacterized protein LOC125467089 isoform X1
poly (ADP-ribose) polymerase family, member 16
protein mono-ADP-ribosyltransferase PARP16
gonadotropin-releasing hormone II receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gonadotropin-releasing hormone II receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gonadotropin-releasing hormone II receptor-like
cytosolic carboxypeptidase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytosolic carboxypeptidase 4, transcript variant X1
cytosolic carboxypeptidase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitochondrial ribosomal protein L46, transcript variant X2
mitochondrial ribosomal protein L46, transcript variant X1
39S ribosomal protein L46, mitochondrial isoform X2
39S ribosomal protein L46, mitochondrial isoform X1
mitochondrial ribosomal protein S11, transcript variant X1
mitochondrial ribosomal protein S11, transcript variant X2
28S ribosomal protein S11, mitochondrial isoform X1
28S ribosomal protein S11, mitochondrial isoform X2
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X6
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X3
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X5
kinesin family member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: UDP-glucuronosyltransferase 2B20-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X4
UDP-glucuronosyltransferase 2A1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
FA complementation group I, transcript variant X1
FA complementation group I, transcript variant X3
FA complementation group I, transcript variant X2
Fanconi anemia group I protein isoform X1
Fanconi anemia group I protein isoform X2
polymerase (DNA directed), gamma, transcript variant X3
polymerase (DNA directed), gamma, transcript variant X2
polymerase (DNA directed), gamma, transcript variant X1
DNA polymerase subunit gamma-1 isoform X3
DNA polymerase subunit gamma-1 isoform X2
DNA polymerase subunit gamma-1 isoform X1
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TopBP1-interacting, checkpoint, and replication regulator, transcript variant X1
TopBP1-interacting, checkpoint, and replication regulator, transcript variant X2
monoacylglycerol lipase ABHD2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monoacylglycerol lipase ABHD2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
EGF-like repeat and discoidin I-like domain-containing protein 3, transcript variant X1
EGF-like repeat and discoidin I-like domain-containing protein 3, transcript variant X2
EGF-like repeat and discoidin I-like domain-containing protein 3, transcript variant X3
EGF-like repeat and discoidin I-like domain-containing protein 3, transcript variant X4
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X1
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X2
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X3
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X4
hyaluronan and proteoglycan link protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3-like isoform X1
hyaluronan and proteoglycan link protein 3-like isoform X2
aggrecan core protein-like, transcript variant X5
aggrecan core protein-like, transcript variant X1
aggrecan core protein-like, transcript variant X4
aggrecan core protein-like, transcript variant X3
aggrecan core protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal biogenesis factor 11 alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
peroxisomal biogenesis factor 11 alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peroxisomal biogenesis factor 11 alpha, transcript variant X3
peroxisomal biogenesis factor 11 alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
peroxisomal membrane protein 11A isoform X1
peroxisomal membrane protein 11A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromodomain helicase DNA binding protein 2, transcript variant X1
chromodomain helicase DNA binding protein 2, transcript variant X2
chromodomain-helicase-DNA-binding protein 2 isoform X2
chromodomain-helicase-DNA-binding protein 2 isoform X1
chromodomain helicase DNA binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 2 isoform X3
chromodomain helicase DNA binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 2 isoform X4
CTS telomere maintenance complex component 1, transcript variant X1
CTS telomere maintenance complex component 1, transcript variant X3
CTS telomere maintenance complex component 1, transcript variant X2
CTS telomere maintenance complex component 1, transcript variant X4
family with sequence similarity 174 member B
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-2,8-sialyltransferase 8B isoform X2
alpha-2,8-sialyltransferase 8B isoform X3
alpha-2,8-sialyltransferase 8B isoform X1
solute carrier organic anion transporter family member 3A1-like, transcript variant X1
solute carrier organic anion transporter family member 3A1-like, transcript variant X2
solute carrier organic anion transporter family member 3A1-like isoform X1
solute carrier organic anion transporter family member 3A1-like isoform X2
synaptic vesicle glycoprotein 2B-like, transcript variant X7
synaptic vesicle glycoprotein 2B-like, transcript variant X5
synaptic vesicle glycoprotein 2B-like, transcript variant X11
synaptic vesicle glycoprotein 2B-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X6
synaptic vesicle glycoprotein 2B-like, transcript variant X9
synaptic vesicle glycoprotein 2B-like isoform X2
synaptic vesicle glycoprotein 2B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch-like protein 25, transcript variant X2
kelch-like protein 25, transcript variant X1
kelch-like protein 25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
interferon-stimulated gene 20 kDa protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane emp24 domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
progestin and adipoQ receptor family member Va, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
membrane progestin receptor gamma-A isoform X2
progestin and adipoQ receptor family member Va, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
membrane progestin receptor gamma-A isoform X1
glucuronic acid epimerase b, transcript variant X5
glucuronic acid epimerase b, transcript variant X2
glucuronic acid epimerase b, transcript variant X1
glucuronic acid epimerase b, transcript variant X3
glucuronic acid epimerase b, transcript variant X4
glucuronic acid epimerase b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
NADPH oxidase, EF-hand calcium binding domain 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X4
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X4
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X2
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X6
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X3
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X5
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X3
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X5
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X6
coronin, actin binding protein, 2Ba, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
coronin, actin binding protein, 2Ba, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coronin, actin binding protein, 2Ba, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
ceroid-lipofuscinosis neuronal protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mothers against decapentaplegic homolog 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mothers against decapentaplegic homolog 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mothers against decapentaplegic homolog 3 isoform X1
mothers against decapentaplegic homolog 3 isoform X2
alpha and gamma adaptin binding protein, transcript variant X2
alpha and gamma adaptin binding protein, transcript variant X1
alpha- and gamma-adaptin-binding protein p34 isoform X2
alpha- and gamma-adaptin-binding protein p34 isoform X1
IQ motif containing H, transcript variant X1
IQ motif-containing protein H isoform X1
IQ motif containing H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
IQ motif-containing protein H isoform X2
chromosome 33 C15orf61 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
chromosome 33 C15orf61 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein C15orf61 homolog isoform X1
uncharacterized protein C15orf61 homolog isoform X2
mitogen-activated protein kinase kinase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X7
dual specificity mitogen-activated protein kinase kinase 5 isoform X1
dual specificity mitogen-activated protein kinase kinase 5 isoform X2
dual specificity mitogen-activated protein kinase kinase 5 isoform X3
dual specificity mitogen-activated protein kinase kinase 5 isoform X4
dual specificity mitogen-activated protein kinase kinase 5 isoform X5
dual specificity mitogen-activated protein kinase kinase 5 isoform X6
dual specificity mitogen-activated protein kinase kinase 5 isoform X7
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X6
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X7
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X3
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X4
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X2
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X5
SKI family transcriptional corepressor 1 homolog-B-like isoform X1
SKI family transcriptional corepressor 1 homolog-B-like isoform X2
SKI family transcriptional corepressor 1 homolog-B-like isoform X3
uncharacterized LOC125467335, transcript variant X2
uncharacterized LOC125467335, transcript variant X1
uncharacterized LOC125467335, transcript variant X3
protein inhibitor of activated STAT, 1b, transcript variant X4
protein inhibitor of activated STAT, 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein inhibitor of activated STAT, 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein inhibitor of activated STAT, 1b, transcript variant X8
protein inhibitor of activated STAT, 1b, transcript variant X6
protein inhibitor of activated STAT, 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein inhibitor of activated STAT, 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein inhibitor of activated STAT, 1b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein inhibitor of activated STAT, 1b, transcript variant X5
calmodulin-like 4b, transcript variant X2
calmodulin-like 4b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mothers against decapentaplegic homolog 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
mothers against decapentaplegic homolog 6b
uncharacterized LOC125467342, transcript variant X2
uncharacterized LOC125467342, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kinesin family member 23, transcript variant X1
kinesin family member 23, transcript variant X3
kinesin family member 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kinesin family member 23, transcript variant X4
TLE family member 3, transcriptional corepressor a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TLE family member 3, transcriptional corepressor a, transcript variant X1
transducin-like enhancer protein 3-A isoform X8
transducin-like enhancer protein 3-A isoform X7
transducin-like enhancer protein 3-A isoform X6
transducin-like enhancer protein 3-A isoform X5
transducin-like enhancer protein 3-A isoform X9
transducin-like enhancer protein 3-A isoform X4
transducin-like enhancer protein 3-A isoform X2
transducin-like enhancer protein 3-A isoform X3
transducin-like enhancer protein 3-A isoform X1
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X3
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X1
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X4
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X6
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X2
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X5
uveal autoantigen with coiled-coil domains and ankyrin repeats-like isoform X3
uveal autoantigen with coiled-coil domains and ankyrin repeats-like isoform X1
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X4
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X2
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X5
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X6
mortality factor 4 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mortality factor 4-like protein 1 isoform X2
mortality factor 4 like 1, transcript variant X4
mortality factor 4 like 1, transcript variant X5
mortality factor 4 like 1, transcript variant X2
mortality factor 4 like 1, transcript variant X1
mortality factor 4-like protein 1 isoform X4
mortality factor 4-like protein 1 isoform X3
mortality factor 4-like protein 1 isoform X1
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cytosolic iron-sulfur assembly component 2A
SPG11 vesicle trafficking associated, spatacsin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 3, subunit Ja
eukaryotic translation initiation factor 3 subunit J-A
CTD small phosphatase-like protein 2, transcript variant X3
CTD small phosphatase-like protein 2, transcript variant X1
CTD small phosphatase-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
BLM RecQ like helicase, transcript variant X2
BLM RecQ like helicase, transcript variant X1
BLM RecQ like helicase, transcript variant X3
Bloom syndrome protein homolog isoform X1
Bloom syndrome protein homolog isoform X2
Ras protein specific guanine nucleotide releasing factor 1, transcript variant X1
Ras protein specific guanine nucleotide releasing factor 1, transcript variant X3
Ras protein specific guanine nucleotide releasing factor 1, transcript variant X2
ras-specific guanine nucleotide-releasing factor 1 isoform X3
ras-specific guanine nucleotide-releasing factor 1 isoform X2
ras-specific guanine nucleotide-releasing factor 1 isoform X1
ankyrin repeat domain-containing protein 34C
uncharacterized protein LOC407663 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
small nuclear RNA activating complex, polypeptide 5, transcript variant X1
small nuclear RNA activating complex, polypeptide 5, transcript variant X4
small nuclear RNA activating complex, polypeptide 5, transcript variant X3
small nuclear RNA activating complex, polypeptide 5, transcript variant X2
snRNA-activating protein complex subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zwilch kinetochore protein, transcript variant X3
zwilch kinetochore protein, transcript variant X1
zwilch kinetochore protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00138
COORDINATES: nucleotide motif:Rfam:12.0:RF00093
mitogen-activated protein kinase kinase 1
dual specificity mitogen-activated protein kinase kinase 1
timeless interacting protein, transcript variant X1
timeless interacting protein, transcript variant X2
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X3
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 156 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DENN/MADD domain containing 4A, transcript variant X1
DENN/MADD domain containing 4A, transcript variant X3
DENN/MADD domain containing 4A, transcript variant X2
C-myc promoter-binding protein isoform X1
C-myc promoter-binding protein isoform X2
C-myc promoter-binding protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
integrator complex subunit 14, transcript variant X1
integrator complex subunit 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
integrator complex subunit 14, transcript variant X2
integrator complex subunit 14 isoform X1
integrator complex subunit 14 isoform X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase
BTB/POZ domain-containing protein 1-like, transcript variant X3
BTB/POZ domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
BTB/POZ domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
BTB/POZ domain-containing protein 1-like, transcript variant X1
BTB/POZ domain-containing protein 1-like
RNA guanine-N7 methyltransferase activating subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
homer scaffold protein 2, transcript variant X4
homer scaffold protein 2, transcript variant X3
homer scaffold protein 2, transcript variant X2
homer scaffold protein 2, transcript variant X1
WASP homolog-associated protein with actin, membranes and microtubules
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
fibronectin type III and SPRY domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
glycine amidinotransferase, mitochondrial
very long-chain acyl-CoA synthetase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
GA binding protein transcription factor subunit beta 1, transcript variant X2
GA binding protein transcription factor subunit beta 1, transcript variant X1
GA-binding protein subunit beta-1 isoform X2
GA-binding protein subunit beta-1 isoform X1
GA binding protein transcription factor subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
putative ubiquitin carboxyl-terminal hydrolase 50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transient receptor potential cation channel, subfamily M, member 7, transcript variant X1
transient receptor potential cation channel subfamily M member 7 isoform X1
transient receptor potential cation channel, subfamily M, member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 7 isoform X2
signal peptide peptidase-like 2A, transcript variant X2
signal peptide peptidase-like 2A, transcript variant X1
signal peptide peptidase-like 2A isoform X2
signal peptide peptidase-like 2A isoform X1
sulfide quinone oxidoreductase, transcript variant X4
sulfide quinone oxidoreductase, transcript variant X1
sulfide quinone oxidoreductase, transcript variant X3
sulfide quinone oxidoreductase, transcript variant X5
sulfide quinone oxidoreductase, transcript variant X2
sulfide quinone oxidoreductase, transcript variant X6
sulfide:quinone oxidoreductase, mitochondrial isoform X3
sulfide:quinone oxidoreductase, mitochondrial isoform X1
sulfide:quinone oxidoreductase, mitochondrial isoform X2
sulfide:quinone oxidoreductase, mitochondrial isoform X4
sulfide:quinone oxidoreductase, mitochondrial isoform X5
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin
biogenesis of lysosome-related organelles complex 1 subunit 6
normal mucosa of esophagus-specific gene 1 protein
spermatogenesis-associated protein 5-like protein 1
AP-3 complex subunit sigma-2-like, transcript variant X2
AP-3 complex subunit sigma-2-like, transcript variant X1
AP-3 complex subunit sigma-2-like isoform X1
alanyl (membrane) aminopeptidase b, tandem duplicate 1
mitochondrial methionyl-tRNA formyltransferase, transcript variant X1
mitochondrial methionyl-tRNA formyltransferase, transcript variant X2
mitochondrial methionyl-tRNA formyltransferase, transcript variant X3
mitochondrial methionyl-tRNA formyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
methionyl-tRNA formyltransferase, mitochondrial isoform X1
methionyl-tRNA formyltransferase, mitochondrial isoform X2
methionyl-tRNA formyltransferase, mitochondrial isoform X3
methionyl-tRNA formyltransferase, mitochondrial isoform X4
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, transcript variant X2